BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Monoferric / Monofer (Ferric derisomaltose) readouts · AssetM
 emo
X-WR-CALDESC:Upcoming readouts of Monoferric / Monofer (Ferric derisomaltos
 e)\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04913649-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 4 readout est. (
 NCT04913649)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 4\, Iron De
 ficiency Anemia.\nStudy: Intravenous Iron to Treat Postoperative Anemia in
  Older Cardiac Surgery Patients\nEstimated primary completion: November 20
 26. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\,
  and it can move.\nDrug page: https://assetmemo.bio/drug/ferric-derisomalt
 ose#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT
 04913649
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06287619-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 2 readout est. (
 NCT06287619)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 2\, Iron De
 ficiency Anemia.\nStudy: Post-operative Intravenous Iron to Treat Iron-def
 iciency Anemia in Patients Undergoing Cardiac Surgery\nEstimated primary c
 ompletion: December 2026. This is a ClinicalTrials.gov estimate\, not a co
 nfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/
 drug/ferric-derisomaltose#upcoming-events\nRegistry record: https://clinic
 altrials.gov/study/NCT06287619
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07236788-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase na readout est. 
 (NCT07236788)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase na.\nStudy:
  Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia
  and Improve the Quality of Life in Obese Patients With Iron Deficiency.\n
 Estimated primary completion: 30 December 2026. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events\nRegistry 
 record: https://clinicaltrials.gov/study/NCT07236788
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05462704-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20270330
DTEND;VALUE=DATE:20270331
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 3 readout est. (
 NCT05462704)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 3\, Iron De
 ficiency Anemia.\nStudy: Intravenous Versus Oral Iron for Treating Iron-De
 ficiency Anemia in Pregnancy\nEstimated primary completion: 30 March 2027.
  This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, an
 d it can move.\nDrug page: https://assetmemo.bio/drug/ferric-derisomaltose
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT054
 62704
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05179226-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 3 readout est. (
 NCT05179226)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 3\, Iron De
 ficiency Anemia.\nStudy: Multi-center Trial of Ferric Derisomaltose in Chi
 ldren 0 to <18 Years of Age With Iron Deficiency Anemia\nEstimated primary
  completion: 30 April 2027. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/ferric-derisomaltose#upcoming-events\nRegistry record: https://clin
 icaltrials.gov/study/NCT05179226
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06898814-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20270601
DTEND;VALUE=DATE:20270602
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 4 readout est. (
 NCT06898814)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 4.\nStudy: 
 The Effects of Intravenous Iron on Mobility in Elderly Patients Following 
 Hip Fracture Surgery\nEstimated primary completion: 1 June 2027. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-
 events\nRegistry record: https://clinicaltrials.gov/study/NCT06898814
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06427343-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20270801
DTEND;VALUE=DATE:20270802
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 4 readout est. (
 NCT06427343)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 4\, Heart F
 ailure.\nStudy: The Effects of Low-Dose Versus High-Dose Intravenous IRON 
 Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure a
 nd Iron Deficiency\nEstimated primary completion: 1 August 2027. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-
 events\nRegistry record: https://clinicaltrials.gov/study/NCT06427343
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05971732-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20270801
DTEND;VALUE=DATE:20270802
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 4 readout est. (
 NCT05971732)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 4\, Heart F
 ailure.\nStudy: The Effects of Ferric Derisomaltose in Patients With Acute
  Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Lif
 e(COREVIVE-HFrEF)\nEstimated primary completion: 1 August 2027. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT05971732
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05991128-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20270801
DTEND;VALUE=DATE:20270802
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 4 readout est. (
 NCT05991128)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 4\, Heart F
 ailure.\nStudy: The Effects of Ferric Derisomaltose in Patients With Acute
  Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Lif
 e\nEstimated primary completion: 1 August 2027. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events\nRegistry 
 record: https://clinicaltrials.gov/study/NCT05991128
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06884280-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 3 readout est. (
 NCT06884280)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 3.\nStudy: 
 Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialy
 sis: The PALaDIN Study\nEstimated primary completion: October 2027. This i
 s a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it ca
 n move.\nDrug page: https://assetmemo.bio/drug/ferric-derisomaltose#upcomi
 ng-events\nRegistry record: https://clinicaltrials.gov/study/NCT06884280
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07314424-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20271001
DTEND;VALUE=DATE:20271002
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 4 readout est. (
 NCT07314424)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 4.\nStudy: 
 The Effect of Preoperative Intravenous Ferric Derisomaltose and EPO and Tr
 anexamic Acid in Patients With Preoperative Anemia or Iron Deficiency in B
 one Tumor\nEstimated primary completion: 1 October 2027. This is a Clinica
 lTrials.gov estimate\, not a confirmed readout date\, and it can move.\nDr
 ug page: https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events\n
 Registry record: https://clinicaltrials.gov/study/NCT07314424
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06929806-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20271201
DTEND;VALUE=DATE:20271202
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 3 readout est. (
 NCT06929806)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 3\, Heart F
 ailure.\nStudy: Multi-center Trial of Ferric Derisomaltose Versus no Intra
 venous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Fail
 ure\nEstimated primary completion: 1 December 2027. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT06929806
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05407987-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20271230
DTEND;VALUE=DATE:20271231
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 3 readout est. (
 NCT05407987)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 3.\nStudy: 
 Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology:
  ERAS (Enhanced Recovery After Surgery)\nEstimated primary completion: 30 
 December 2027. This is a ClinicalTrials.gov estimate\, not a confirmed rea
 dout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ferric
 -derisomaltose#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT05407987
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05929729-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20280901
DTEND;VALUE=DATE:20280902
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 4 readout est. (
 NCT05929729)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 4\, Iron De
 ficiency Anemia.\nStudy: Iron Deficiency Anemia (IDA) and the Brain\nEstim
 ated primary completion: 1 September 2028. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events\nRegistry recor
 d: https://clinicaltrials.gov/study/NCT05929729
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07659184-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20280930
DTEND;VALUE=DATE:20281001
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 4 readout est. (
 NCT07659184)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 4.\nStudy: 
 IRONCARE: Iron Treatment in Older Patients With Hip Fractures\nEstimated p
 rimary completion: 30 September 2028. This is a ClinicalTrials.gov estimat
 e\, not a confirmed readout date\, and it can move.\nDrug page: https://as
 setmemo.bio/drug/ferric-derisomaltose#upcoming-events\nRegistry record: ht
 tps://clinicaltrials.gov/study/NCT07659184
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05763043-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20281031
DTEND;VALUE=DATE:20281101
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 1 readout est. (
 NCT05763043)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 1.\nStudy: 
 Monoferric for Prenatal Iron Deficiency\nEstimated primary completion: Oct
 ober 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ferric-der
 isomaltose#upcoming-events\nRegistry record: https://clinicaltrials.gov/st
 udy/NCT05763043
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06248749-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20281201
DTEND;VALUE=DATE:20281202
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 3 readout est. (
 NCT06248749)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 3.\nStudy: 
 Effect of Intravenously Iron Infusion on the Prevention and Treatment of A
 nemia in Ovarian Cancer\nEstimated primary completion: 1 December 2028. Th
 is is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and i
 t can move.\nDrug page: https://assetmemo.bio/drug/ferric-derisomaltose#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT062487
 49
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07643818-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20290731
DTEND;VALUE=DATE:20290801
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 2 readout est. (
 NCT07643818)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 2\, Heart F
 ailure.\nStudy: Intravenous Iron to Improve Symptoms\, Quality of Life and
  Exercise Capacity in HFpEF With Iron Deficiency\nEstimated primary comple
 tion: July 2029. This is a ClinicalTrials.gov estimate\, not a confirmed r
 eadout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ferr
 ic-derisomaltose#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT07643818
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07238972-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20300831
DTEND;VALUE=DATE:20300901
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 4 readout est. (
 NCT07238972)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 4\, Iron De
 ficiency Anemia.\nStudy: Postoperative Intravenous Ferric Derisomaltose fo
 r Prevention of Long-term Anemia After Cardiac Surgery\nEstimated primary 
 completion: August 2030. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/ferric-derisomaltose#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT07238972
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07686692-591@assetmemo.bio
DTSTAMP:20261121T004952Z
DTSTART;VALUE=DATE:20300831
DTEND;VALUE=DATE:20300901
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 4 readout est. (
 NCT07686692)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 4\, Heart F
 ailure.\nStudy: IV Iron Therapy for Older Adults With Heart Failure With P
 reserved Ejection Fraction and Iron Deficiency\nEstimated primary completi
 on: August 2030. This is a ClinicalTrials.gov estimate\, not a confirmed r
 eadout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ferr
 ic-derisomaltose#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT07686692
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
